![Alison Finger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alison Finger
Director/Board Member at
ADMA BIOLOGICS, INC.
Net worth: 278 733 $ as of 30/05/2026
Profile
Alison C.
Finger currently serves as an Independent Director at ADMA Biologics, Inc. since 2023 and as an Independent Director at KeifeRx LLC.
Former positions include Director at Pharmaceutical Industry Working Group, Managing Director at Bristol-Myers Squibb (NZ) Ltd., Independent Non-Executive Director at Vascular Biogenics Ltd. from 2021 to 2022, Managing Director at Bristol-Myers Squibb Australia Pty Ltd. from 2007 to 2009, Director at Medicines Australia, Director at Alliance for Regenerative Medicine, Director at Regenerative Medicine Foundation, Independent Director at Decibel Therapeutics, Inc. from 2021 to 2023, Chief Commercial Officer at Genetix Biotherapeutics, Inc. from 2015 to 2021, and VP-Global Commercialization at Bristol-Myers Squibb Pharmaceuticals Ltd. from 2009 to 2014.
Education includes undergraduate studies at St. Lawrence University and an MBA from The Fuqua School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ADMA BIOLOGICS, INC. 0.02% | 30/03/2026 | 34,929 ( 0.02% ) | 278 733 $ | 30/05/2026 |
Alison Finger active positions
| Companies | Position | Start |
|---|---|---|
| ADMA BIOLOGICS, INC. | Director/Board Member | 27/09/2023 |
KeifeRx LLC
 KeifeRx LLC BiotechnologyHealth Technology Operates as a clinical stage biotechnology company which develops tyrosine kinase inhibitors to treat neurodegenerative diseases | Director/Board Member | - |
Former positions of Alison Finger
| Companies | Position | End |
|---|---|---|
| DECIBEL THERAPEUTICS, INC. | Director/Board Member | 21/09/2023 |
| NOTABLE LABS, LTD. | Director/Board Member | 31/07/2022 |
| GENETIX BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 31/12/2020 |
Bristol-Myers Squibb Pharmaceuticals Ltd.
 Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 30/04/2014 |
Bristol-Myers Squibb Australia Pty Ltd.
 Bristol-Myers Squibb Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Researches, develops and markets biopharmaceutical medicines | Chief Executive Officer | 31/12/2008 |
Training of Alison Finger
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
29
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
ADMA Biologics, Inc.
 ADMA Biologics, Inc. BiotechnologyHealth Technology Develops, manufactures and markets specialty biologics | Health Technology |
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
St. Lawrence University
 St. Lawrence University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vascular Biogenics Ltd.
 Vascular Biogenics Ltd. BiotechnologyHealth Technology Develops novel treatments for atherosclerosis and cancer | Health Technology |
Bristol-Myers Squibb Australia Pty Ltd.
Bristol-Myers Squibb Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Researches, develops and markets biopharmaceutical medicines | Health Technology |
Medicines Australia
 Medicines Australia Pharmaceuticals: MajorHealth Technology Manufactures and supplies medicines and vaccines | Health Technology |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Pharmaceutical Industry Working Group | |
Regenerative Medicine Foundation
 Regenerative Medicine Foundation Medical SpecialtiesHealth Technology Develops therapies for disease and translate | Health Technology |
The Fuqua School of Business
 The Fuqua School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Decibel Therapeutics, Inc.
 Decibel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for hearing and balance disorders | Health Technology |
Bristol-Myers Squibb (NZ) Ltd. | |
KeifeRx LLC
KeifeRx LLC BiotechnologyHealth Technology Operates as a clinical stage biotechnology company which develops tyrosine kinase inhibitors to treat neurodegenerative diseases | Health Technology |
- Stock Market
- Insiders
- Alison Finger
